Sex disparities in patients with suspected COVID-19 presenting at an emergency department in Switzerland
AIMS OF THE STUDY: In the global COVID-19 pandemic, female sex is associated with comparable infection rates but better outcome. However, most studies lacked appropriate controls. We investigated whether these sex disparity findings are specific to patients with COVID-19 or generalizable to patients presenting to the emergency room (ER) with similar symptoms but no COVID-19.
METHODS: In this prospective cohort study, consecutive patients presenting with symptoms suggestive of COVID-19 were recruited at the ER of the University Hospital Basel, Switzerland from March to June 2020. Patients were categorized as SARS-CoV-2 positive (cases) or negative (controls) based on nasopharyngeal PCR swab tests. The final clinical diagnosis was determined for all patients. The primary outcome was a composite of intensive care admission, rehospitalization for respiratory distress and all-cause death within 30 days. We used Kaplan–Meier curves and Cox proportional hazards models to explore associations between sex and outcomes.
RESULTS: Among 1,081 consecutive ER patients, 191 (18%) tested positive for SARS-CoV-2, with an even sex distribution (17.9% female vs. 17.5% male, p = 0.855). In COVID-19 patients, female sex was associated with lower risk of hospitalization (51% vs. 66%, p = 0.034), lower necessity of haemodynamic support (8% vs. 20%, p = 0.029), lower rates of intubation (10% vs. 21%, p = 0.037) and the primary outcome (18% vs. 31%, p = 0.045; age-adjusted HR 0.536, 95%CI 0.290–0.989, p = 0.046) compared with male sex. Sex disparities were most prominent in patients ≥55 years (HR for composite primary outcome in women 0.415, 95%CI 0.201–0.855, p = 0.017). In contrast to the COVID-19 patients, no sex-specific differences in outcomes were observed in the unselected overall control group (age-adjusted HR 0.844, 95%CI 0.560–1.273, p = 0.419) or in a subgroup of controls with upper respiratory tract infections or pneumonia (age-adjusted HR 0.840, 95%CI 0.418–1.688, p = 0.624).
CONCLUSION: In this unselected, consecutive cohort study at a tertiary hospital in Switzerland, female sex is associated with better outcome in patients presenting to the ER with COVID-19. These sex disparities seem to be at least partly specific to COVID-19, as they were not observed in comparable controls.
- Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-20. Epub 2020/02/29. doi: https://doi.org/10.1056/NEJMoa2002032. PubMed PMID: 32109013; PubMed Central PMCID: PMCPMC7092819.
- Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. 2020;11(1):29. Epub 2020/05/27. doi: https://doi.org/10.1186/s13293-020-00304-9. PubMed PMID: 32450906; PubMed Central PMCID: PMCPMC7247289.
- Abate BB, Kassie AM, Kassaw MW, Aragie TG, Masresha SA. Sex difference in coronavirus disease (COVID-19): a systematic review and meta-analysis. BMJ Open. 2020;10(10):e040129. Epub 2020/10/09. doi: https://doi.org/10.1136/bmjopen-2020-040129. PubMed PMID: 33028563; PubMed Central PMCID: PMCPMC7539579.
- Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, et al. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front Public Health. 2020;8:152. Epub 2020/05/16. doi: https://doi.org/10.3389/fpubh.2020.00152. PubMed PMID: 32411652; PubMed Central PMCID: PMCPMC7201103.
- Iaccarino G, Grassi G, Borghi C, Carugo S, Fallo F, Ferri C, et al. Gender differences in predictors of intensive care units admission among COVID-19 patients: The results of the SARS-RAS study of the Italian Society of Hypertension. PLoS One. 2020;15(10):e0237297. Epub 2020/10/07. doi: https://doi.org/10.1371/journal.pone.0237297. PubMed PMID: 33022004; PubMed Central PMCID: PMCPMC7537902.
- Sex gaC-GH. [13 March, 2021]. Available from: https://globalhealth5050.org/the-sex-gender-and-covid-19-project/
- von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP ; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014 Dec;12(12):1495–9. https://doi.org/10.1016/j.ijsu.2014.07.013
- Zhu D, Chung HF, Dobson AJ, Pandeya N, Giles GG, Bruinsma F, et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public Health. 2019;4(11):e553-e64. Epub 2019/10/08. doi: https://doi.org/10.1016/s2468-2667(19)30155-0. PubMed PMID: 31588031; PubMed Central PMCID: PMCPMC7118366. https://doi.org/10.1016/S2468-2667(19)30155-0
- Muller B, Harbarth S, Stolz D, Bingisser R, Mueller C, Leuppi J, et al. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis. 2007;7:10. Epub 2007/03/06. doi: https://doi.org/10.1186/1471-2334-7-10. PubMed PMID: 17335562; PubMed Central PMCID: PMCPMC1821031.
- Suleyman G, Fadel RA, Malette KM, Hammond C, Abdulla H, Entz A, et al. Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit. JAMA Netw Open. 2020;3(6):e2012270. Epub 2020/06/17. doi: https://doi.org/10.1001/jamanetworkopen.2020.12270. PubMed PMID: 32543702; PubMed Central PMCID: PMCPMC7298606.
- Tolia VM, Chan TC, Castillo EM. Preliminary Results of Initial Testing for Coronavirus (COVID-19) in the Emergency Department. West J Emerg Med. 2020;21(3):503-6. Epub 2020/04/01. doi: https://doi.org/10.5811/westjem.2020.3.47348. PubMed PMID: 32223871; PubMed Central PMCID: PMCPMC7234708.
- Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, et al. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. JAMA Intern Med. 2020;180(10):1345-55. Epub 2020/07/16. doi: https://doi.org/10.1001/jamainternmed.2020.3539. PubMed PMID: 32667669; PubMed Central PMCID: PMCPMC7364371.
- Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020;81(2):e16-e25. Epub 2020/04/27. doi: https://doi.org/10.1016/j.jinf.2020.04.021. PubMed PMID: 32335169; PubMed Central PMCID: PMCPMC7177098.
- Lakbar I, Luque-Paz D, Mege JL, Einav S, Leone M. COVID-19 gender susceptibility and outcomes: A systematic review. PLoS One. 2020;15(11):e0241827. Epub 2020/11/04. doi: https://doi.org/10.1371/journal.pone.0241827. PubMed PMID: 33141872; PubMed Central PMCID: PMCPMC7608911 speaker for MSD, Pfizer and as consultant for Amomed, Aguettant and Gilead. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
- Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016 Oct;16(10):626–38. https://doi.org/10.1038/nri.2016.90
- Scully EP, Haverfield J, Ursin RL, Tannenbaum C, Klein SL. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat Rev Immunol. 2020;20(7):442-7. Epub 2020/06/13. doi: https://doi.org/10.1038/s41577-020-0348-8. PubMed PMID: 32528136; PubMed Central PMCID: PMCPMC7288618.
- Maleki Dana P, Sadoughi F, Hallajzadeh J, Asemi Z, Mansournia MA, Yousefi B, et al. An Insight into the Sex Differences in COVID-19 Patients: What are the Possible Causes? Prehosp Disaster Med. 2020;35(4):438-41. Epub 2020/07/01. doi: https://doi.org/10.1017/s1049023x20000837. PubMed PMID: 32600476; PubMed Central PMCID: PMCPMC7327162. https://doi.org/10.1017/S1049023X20000837
- Potluri T, Fink AL, Sylvia KE, Dhakal S, Vermillion MS, Vom Steeg L, et al. Age-associated changes in the impact of sex steroids on influenza vaccine responses in males and females. NPJ Vaccines. 2019;4:29. Epub 2019/07/18. doi: https://doi.org/10.1038/s41541-019-0124-6. PubMed PMID: 31312529; PubMed Central PMCID: PMCPMC6626024.
- Gemmati D, Bramanti B, Serino ML, Secchiero P, Zauli G, Tisato V. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males? Int J Mol Sci. 2020;21(10). Epub 2020/05/20. doi: https://doi.org/10.3390/ijms21103474. PubMed PMID: 32423094; PubMed Central PMCID: PMCPMC7278991.
- Palaiodimos L, Kokkinidis DG, Li W, Karamanis D, Ognibene J, Arora S, et al. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism. 2020;108:154262. Epub 2020/05/19. doi: https://doi.org/10.1016/j.metabol.2020.154262. PubMed PMID: 32422233; PubMed Central PMCID: PMCPMC7228874.
- Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. Epub 2020/03/15. doi: https://doi.org/10.1016/S0140-6736(20)30566-3. PubMed PMID: 32171076; PubMed Central PMCID: PMCPMC7270627.